SIRPα

Gene

Also known as: SIRPα

Related News

Novel Anti-CD47 Fusion Protein CO-005 Overcomes Rituximab Resistance in Lymphoma Models

Jun 19, 2026

CO-005, a humanized anti-CD47 fusion protein from Caedo Oncology, showed potent antitumor activity in preclinical models of B-cell lymphoma, including rituximab-resistant tumors. The therapy induces programmed cancer cell death while disrupting immune checkpoints, offering a potential solution to CD20 resistance.

Monoclonal Antibody Pipeline and Market Reports Released for 2026

Feb 16, 2026

Three comprehensive reports examine the monoclonal antibody landscape, covering CD47-targeted immunotherapy pipelines, competitive analysis of 180+ companies developing mAb therapeutics, and recombinant antibody market forecasts through 2033.

FDA Grants Orphan Drug Designation to HanchorBio's HCB101 for Gastric Cancer Treatment

Feb 13, 2026

The U.S. FDA granted orphan drug designation to HCB101, a next-generation immunotherapy from HanchorBio, for treating gastric cancer including HER2-positive and HER2-negative subtypes.